[{"indications": "Indications\u00a0adjunct to dexamethasone and a 5HT3-receptor antagonist\r\nin preventing nausea and vomiting associated with moderately and highly\r\nemetogenic chemotherapy", "name": "APREPITANT", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.6 Drugs used in nausea and vertigo", "Neurokinin-receptor antagonists", "APREPITANT"], "cautions": "Cautions\u00a0interactions: Appendix 1 (aprepitant)", "side-effects": "Side-effects\u00a0hiccups, dyspepsia, diarrhoea, constipation, anorexia;\r\nasthenia, headache, dizziness; less commonly weight\r\nchanges, dry mouth, colitis, flatulence, stomatitis, abdominal pain,\r\nduodenal ulcer, taste disturbance, oedema, bradycardia, palpitations,\r\ncough, euphoria, anxiety, confusion, drowsiness, thirst, abnormal\r\ndreams, chills, hyperglycaemia, polyuria, anaemia, dysuria, haematuria,\r\nhyponatraemia, neutropenia, myalgia, conjunctivitis, pharyngitis,\r\nsneezing, tinnitus, sweating, pruritus, rash, acne, photosensitivity,\r\nand flushing; dyspnoea, insomnia, visual disturbances, dysarthria,\r\nurticaria, and Stevens-Johnson syndrome also reported", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128411.htm", "doses": ["adult over 18 years 125\u00a0mg\r\n1 hour before chemotherapy, then 80\u00a0mg daily as a single dose for\r\nthe next 2 days; consult product literature for dose of concomitant\r\ncorticosteroid and 5HT3-receptor antagonist"], "pregnancy": "Pregnancy\u00a0avoid unless potential benefit outweighs risk\u2014no\r\ninformation available"}]